Research Roundup: Aug 26, 2025
- Lex Pelger
- 7 minutes ago
- 3 min read

Best of cannabinoid science this week...
In people with anxiety, a full-spectrum CBD solution significantly reduced anxiety symptoms as well as improving mood, sleep & quality of life
Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study
For chemotherapy-induced peripheral neuropathy (nerve pain), cannabis reduced symptoms & improved quality of life with THC showing greater improvements in burning sensation & cold sensations & the combination of CBD & THC yielding the greatest symptom relief
Comparative Effects of THC and CBD on Chemotherapy-Induced Peripheral Neuropathy: Insights from a Large Real-World Self-Reported Dataset
In people with chronic pain, those who started medical cannabis had significantly decreased opioid consumption as well as disability & insomnia levels
Opioid reduction in patients with chronic non-cancer pain undergoing treatment with medicinal cannabis
In people with schizophrenia, a cohort analysis found cannabis use associated with a reduced risk for metabolic syndrome including reduced weight, waist circumference, BMI & triglycerides as well as higher HDL
Cannabis Use and Cardiometabolic Risk in Schizophrenia
In people with glaucoma, one dose of dronabinol (pharmaceutical THC) increased ocular blood flow & vessel density
Single oral administration of dronabinol increases ocular blood flow in patients with glaucoma
In a case report of treatment-resistant chronic pancreatitis (inflammation of the pancreas, often with severe pain), a CBD-rich medical cannabis formulation substantially reduced pain, stopped acute episodes, improved appetite & enhanced quality of life
Medical cannabis for the management of pain in chronic pancreatitis with recurrent exacerbations: a case report
In dogs with osteoarthritis, an extract with CBDA, CBD, THCA & THC lowered their pain scores & improved their osteoarthritis scores
Randomized and Blind Evaluation of the Efficacy of a Full-Spectrum Oral Cannabis sativa Oil Extract, Standardized Based on CBD-A, CBD and THC-A, THC in Canines with Chronic Osteoarthritis
For multiple sclerosis, this review & meta-analysis of 9 studies found notable improvements for spasticity, particularly over longer durations
Assessing the Role of Cannabis in Managing Spasticity in Multiple Sclerosis: A Systematic Review and Meta-Analysis
For aging, longevity & cannabinoids, this review of 18 studies found promising preclinical results for “improved lifespan, cognitive function, inflammation, memory, sleep quality, and social interaction” with THC showing potential benefits at low doses & drawbacks at high doses
The impact of cannabis use on ageing and longevity: a systematic review of research insights
For cognitive function in older adults, a review of CBD's effects
Cannabidiol (CBD) and cognitive function in older adults: a mini review
For depression, this review focused on dysregulation of the endocannabinoid system & that many of the most common treatments modulate endocannabinoid levels (nice charts)
Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions
For atopic dermatitis (eczema), a review on the therapeutic potential of cannabinoids
Therapeutic potential of cannabinoids for treating atopic dermatitis
For cannabinoids & exercise, a review of their combined effects on the brain
Considering the Effects of Cannabinoids and Exercise on the Brain: A Narrative Review
For bone healing & fusion, this review found that activating the CB2 receptor or using CBD improved bone production & repair, while activating the CB1 receptor with THC lowered bone-mineral density (though THC was neutral over short time periods)
The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine
For dentistry, a review of the evidence for cannabinoid medicines
Cannabis: What We Use, Why It Matters, and When It Is Prescribed (Ethics, Policy, and Practice)
In a rat model of aging, intermittent cannabis use protected the brain & reduced age-related cognitive decline
Exploring the impact of chronic intermittent EU-GMP certified Cannabis sativa L. therapy and its relevance in a rat model of aging
In a mouse model of chronic pain, the combination of CBD & the terpene beta-caryophyllene produced pain-killing & antidepressant effects with a significant reduction in neuroinflammation
Phytocannabinoids in Combination: Chronic Pain
In a mouse model of social defeat, CBD prevented social avoidance & prevented the increased reward from cocaine induced by social defeat via modulation of the genetic expression of cannabinoid receptors
Cannabidiol prevents social avoidance, potentiation of cocaine reward and gene expression alterations induced by exposure to intermittent social defeat in mice
Comments